Patents by Inventor Wenshu LU

Wenshu LU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein for neutralizing programmed necrocytosis promotion antibody, and application of protein
    Patent number: 11434270
    Abstract: Provided is polypeptide which derives from wild type TNF a and inhibits necrocytosis. The polypeptide contains 10-200 amino acid residues and a sequence QLVVPSE. Also provided is a pharmaceutical composition containing polypeptide. The polypeptide and the pharmaceutical composition containing the polypeptide are capable of inhibiting necrocytosis, thereby being used for treating inflammatory diseases.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: September 6, 2022
    Assignee: SHANGHAI JW INFLINHIX CO., LTD.
    Inventors: Shisong Jiang, Wenshu Lu
  • Antibody facilitating programmed necrosis of cells and application thereof
    Patent number: 11319366
    Abstract: The present invention provides an antibody facilitating programmed necrosis of cells. The antibody can cause programmed necrosis of cells in the presence of tumor necrosis factor (TNF). Therefore, an inhibitor for the antibody can be used in the treatment of inflammatory diseases. Further, the present invention provides the application of the antibody facilitating programmed necrosis of cells in the inflammatory disease prognosis.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: May 3, 2022
    Assignee: SHANGHAI JW INFLINHIX CO., LTD.
    Inventors: Shisong Jiang, Wenshu Lu
  • PROTEIN FOR NEUTRALIZING PROGRAMMED NECROCYTOSIS PROMOTION ANTIBODY, AND APPLICATION OF PROTEIN
    Publication number: 20190144517
    Abstract: Provided is polypeptide which derives from wild type TNF รก and inhibits necrocytosis. The polypeptide contains 10-200 amino acid residues and a sequence QLVVPSE. Also provided is a pharmaceutical composition containing polypeptide. The polypeptide and the pharmaceutical composition containing the polypeptide are capable of inhibiting necrocytosis, thereby being used for treating inflammatory diseases.
    Type: Application
    Filed: November 25, 2016
    Publication date: May 16, 2019
    Inventors: Shisong JIANG, Wenshu LU
  • ANTIBODY FACILITATING PROGRAMMED NECROSIS OF CELLS AND APPLICATION THEREOF
    Publication number: 20190062417
    Abstract: The present invention provides an antibody facilitating programmed necrosis of cells. The antibody can cause programmed necrosis of cells in the presence of tumor necrosis factor (TNF). Therefore, an inhibitor for the antibody can be used in the treatment of inflammatory diseases. Further, the present invention provides the application of the antibody facilitating programmed necrosis of cells in the inflammatory disease prognosis.
    Type: Application
    Filed: July 18, 2016
    Publication date: February 28, 2019
    Inventors: Shisong JIANG, Wenshu LU